FDA Approves an Experimental Treatment of Various Blood Malignancies for Clinical Trials
According to a story from First World Pharma, the biopharmaceutical company Mustang Bio, Inc. recently announced that the US Food and Drug Administration (FDA) has approved their investigational new drug…